U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511205) titled 'A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity' on March 26.
Brief Summary: The purpose of the study is to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of AZD1043 following single and multiple ascending doses in healthy adult participants living with overweight and/or obesity, including participants of Japanese and Chinese descent.
Study Start Date: March 31
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Obesity
Intervention:
DRUG: AZD1043
Single or multiple doses o...